These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 7490224)

  • 1. Re-Exploring the Anthracycline Chemical Space for Better Anti-Cancer Compounds.
    van Gelder MA; van der Zanden SY; Vriends MBL; Wagensveld RA; van der Marel GA; Codée JDC; Overkleeft HS; Wander DPA; Neefjes JJC
    J Med Chem; 2023 Aug; 66(16):11390-11398. PubMed ID: 37561481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents.
    Wander DPA; van der Zanden SY; van der Marel GA; Overkleeft HS; Neefjes J; Codée JDC
    J Med Chem; 2020 Nov; 63(21):12814-12829. PubMed ID: 33064004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of glycosylated bacterial natural products.
    Elshahawi SI; Shaaban KA; Kharel MK; Thorson JS
    Chem Soc Rev; 2015 Nov; 44(21):7591-697. PubMed ID: 25735878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
    Tevyashova A; Sztaricskai F; Batta G; Herczegh P; Jeney A
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4783-9. PubMed ID: 15324908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone.
    Renneberg B; Li YM; Laatsch H; Fiebig HH
    Carbohydr Res; 2000 Dec; 329(4):861-72. PubMed ID: 11125829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
    Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
    J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
    Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anthracycline antibiotics 10-epi-oxaunomycin and 10-epi-11-deoxyoxaunomycin.
    Johdo O; Nishida H; Okamoto R; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1995 Oct; 48(10):1153-8. PubMed ID: 7490224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the sugar moiety in the pharmacological activity of anthracyclines: development of a novel series of disaccharide analogs.
    Zunino F; Pratesi G; Perego P
    Biochem Pharmacol; 2001 Apr; 61(8):933-8. PubMed ID: 11286984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and antitumor activity of new analogs of anthracycline antibiotics modified by aglycon].
    Olsuf'eva EN
    Bioorg Khim; 1990 Nov; 16(11):1445-64. PubMed ID: 2096823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of anthracyclines in the era of targeted therapy.
    Cortés-Funes H; Coronado C
    Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.